Yarrow Bioscience Inc (YARW) — Financial Flexibility Index

Latest as of March 2026: -3.30x

Yarrow Bioscience Inc (YARW) has a Financial Flexibility Index of -3.30x as of March 2026. Free cash flow of $-4.08 Million (operating CF $-4.08 Million minus capex $0.00) represents -3% of total liabilities ($1.24 Million). Explore YARW operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Financial Flexibility Index

-3.30x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-4.08 Million
Operating CF − Capex

Total Liabilities

$1.24 Million
USD

Capital Expenditures

$0.00
USD

Yarrow Bioscience Inc Financial Flexibility Index (2015–2025)

Historical Financial Flexibility Index trend for Yarrow Bioscience Inc across 11 annual periods.

Annual Financial Flexibility Index for Yarrow Bioscience Inc (2015–2025)

Year-by-year free cash flow to debt coverage for Yarrow Bioscience Inc. For the full cash flow conversion analysis, see how efficiently does Yarrow Bioscience Inc generate cash.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -13.83x $-33.12 Million $-33.12 Million $2.40 Million ▼ -505.4%
2024 -2.28x $-33.85 Million $-33.97 Million $14.82 Million ▲ +19.3%
2023 -2.83x $-25.34 Million $-25.34 Million $8.95 Million ▲ +7.3%
2022 -3.06x $-29.20 Million $-29.20 Million $9.56 Million ▲ +0.2%
2021 -3.06x $-56.37 Million $-56.37 Million $18.41 Million ▼ -25.7%
2020 -2.44x $-136.97 Million $-137.08 Million $56.25 Million ▲ +60.1%
2019 -6.11x $-65.09 Million $-65.10 Million $10.66 Million ▼ -10.9%
2018 -5.51x $-52.59 Million $-52.73 Million $9.55 Million ▼ -2317.7%
2017 -0.23x $-28.22 Million $-28.25 Million $123.90 Million ▼ -620.5%
2016 -0.03x $-2.26 Million $-2.29 Million $71.49 Million ▲ +54.8%
2015 -0.07x $-4.18 Million $-4.18 Million $59.84 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities